Startups
Onepot AI raises $13M to simplify chemical drug creation
Onepot AI secures $13M to accelerate small-molecule synthesis with AI and automated labs, helping pharma companies develop drug compounds faster and more efficiently.
1 article
Onepot AI secures $13M to accelerate small-molecule synthesis with AI and automated labs, helping pharma companies develop drug compounds faster and more efficiently.
Written by the reporters who cover each beat. Unsubscribe in one click.